Successful treatment of lymphomatoid papulosis with photodynamic therapy

Australasian Journal of Dermatology

Volumn 50, Issue 2, 2009, Pages 129-132

  Rodrigues, Michelle ^a,b   McCormack, Christopher ^a,b   Yap, Lee Mei ^a   Prince, H Miles ^a   Roberts, Hugh ^a   Williams, Richard ^c   Foley, Peter ^a,c  

^a Peter MacCallum Cancer Centre ^*  (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

CD 30; Lymphocytic disorders; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; CLOBETASOL PROPIONATE; METHOTREXATE; NICOTINAMIDE; TETRACYCLINE; TRIAMCINOLONE ACETONIDE;

ABDOMEN; ADULT; ARM; ARTICLE; CASE REPORT; DERMIS; DRUG WITHDRAWAL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LEG; LYMPHOCYTIC INFILTRATION; LYMPHOMATOID PAPULOSIS; PAPULE; PHOTODYNAMIC THERAPY; SIDE EFFECT; SKIN BIOPSY; SKIN NODULE; TREATMENT OUTCOME;

EID: 67651180976     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2008.00505.x     Document Type: Article

References (29)

1. Willemze R, Jaffe E, Burg G, Cerroni L, Berti E, Swerdlow S et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768 85.
2. Basarab T, Fraser-Andrews EA, Orchard G, Whittaker S, Russel-Jones R. Lymphomatoid papulosis in association with mycosis fungoides: A study of 15 cases. Br. J. Dermatol. 1998 139 : 630 8.
3. Bekkenk MW, Geelen FA, van Voorst Vader PC, Heule F, Geerts ML, van Vloten WA, Meijer CJ, Willemze R. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: A report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000 95 : 3653 61.
4. Whittaker SJ, MacKie RM. Cutaneous lymphomas and lymphocytic infiltrates. In : Burns T, Breathnach S, Cox N, Griffiths C (eds). Rook's Textbook of Dermatology, Vol. 1, 7th edn. Oxford: Blackwell Science, 2004 54 : 1 53.
5. Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J. Am. Acad. Dermatol. 1996 34 : 470 81.
6. Meisenheimer JL. Novel use of 308nm excimer laser to treat a primary cutaneous CD30+ lymphoproliferative nodule. J. Drugs Dermatol. 2007 6 : 440 2.
7. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, Roelandts R, Wennberg AM, Morton CA. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J. Am. Acad. Dermatol. 2007 56 : 125 43.
8. Foley P. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. J. Dermatol. Treat. 2003 14 : 15 22.
9. Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: A prospective, randomized study. J. Dermatol. Treat. 2003 14 : 99 106.
10. Morton CA. Methyl aminolevulinate: Actinic keratoses and Bowen's disease. Dermatol. Clin. 2007 25 : 81 7.
11. Szeimies RM. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma. Dermatol. Clin. 2007 25 : 89 94.
12. Hauschild A, Lischner S, Lange-Asschenfeldt B, Egberts F. Treatment of actinic cheilitis using photodynamic therapy with methyl aminolevulinate: report of three cases. Dermatol. Surg. 2005 31 : 1344 47.
13. Fernández-Guarino M, Harto A, Pérez-Garcia B, Martin-González M, Urrutia S, Jaén P. Photodynamic therapy in disseminated superficial actinic porokeratosis (Letter). J. Eur. Acad. Dermatol. Venereol. 2008 April 22, [Epub ahead of print], DOI: 10.1111/j.1468-3083.2008. 02753.x.
14. Hong SB, Lee MH. Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris. Photodermatol. Photoimmunol. Photomed. 2005 21 : 322 5.
15. Gold M. Aminolevulinic acid photodynamic therapy for Hidradenitis Suppurativa. Dermatol. Clin. 2007 25 : 67 73. (Pubitemid 44780057)
16. Akilov OE, Kosaka S, O'Riordan K, Hasan T. Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation. Photochem. Photobiol. Sci. 2007 6 : 1067 75.
17. Horn M, Wolf P. Topical methyl aminolevulinate photodynamic therapy for the treatment of folliculitis. Photodermatol. Photoimmunol. Photomed. 2007 23 : 145 7.
18. Calzavara-Pinton PG, Venturini M, Capezzera R, Sala R, Zane C. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid. Photodermatol. Photoimmunol. Photomed. 2004 20 : 144 7.
19. Zane C, Venturini M, Sala R, Calzavara-Pinton P. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma. Photodermatol. Photoimmunol. Photomed. 2006 22 : 254 8.
20. Recio ED, Zambrano B, Alonso ML, de Eusebio E, Martín M, Cuevas J, Jaén P. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: A report of two cases and review of the literature. Int. J. Dermatol. 2008 47 : 410 13.
21. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br. J. Dermatol. 2007 156 : 793 801.
22. Dragieva G, Hafner J, Dummer R, Schmid-Grendelmeier P, Roos M, Prinz BM, Bur G, Binswanger U, Kempf W. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004 77 : 115 21.
23. Dragieva G, Prinz BM, Hafter J, Drummer R, Burg G, Binswanger U, Kempf W. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratoses in transplant recipients. Br. J. Dermatol. 2004 151 : 196 200.
24. Wulf HC, Pavel S, Stender I, Bakker-Wensvenn CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm. Venereol. 2006 86 : 25 8.
25. Liu Y, Viau G, Bissonnette R. Multiple large-surface photodynamic therapy sessions with topical or systemic aminolevulinic acid and blue light in UV-exposed hairless mice. J. Cutan. Med. Surg. 2004 8 : 131 9.
26. Caty V, Liu Y, Viau G, Bissonnette R. Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice. Br. J. Dermatol. 2006 154 : 740 2.
27. Sharfaei S, Juzenas P, Moan J, Bissonnette R. Weekly topical application of methylaminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice. Arch. Dermatol. Res. 2002 294 : 237 42.
28. Sharfaei S, Viau G, Li H, Bouffard D, Bissonnette R. Systemic photodynamic therapy with aminolaevulinic acid delayed the appearance of ultraviolet-induced skin tumours in mice. Br. J. Dermatol. 2001 144 : 1207 14.
29. Bissonnette R, Bergeron A, Liu Y. Large surface photodynamic therapy with aminolevulinic acid: Treatment of actinic keratoses and beyond. J. Drugs Dermatol. 2004 3 (Suppl. 1 S26 31.